MPPP
Structural formula | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
![]() |
|||||||||||||
General | |||||||||||||
Surname | MPPP | ||||||||||||
other names |
|
||||||||||||
Molecular formula | C 15 H 21 NO 2 | ||||||||||||
External identifiers / databases | |||||||||||||
|
|||||||||||||
Drug information | |||||||||||||
Drug class | |||||||||||||
properties | |||||||||||||
Molar mass | 247.33 g mol −1 | ||||||||||||
safety instructions | |||||||||||||
|
|||||||||||||
As far as possible and customary, SI units are used. Unless otherwise noted, the data given apply to standard conditions . |
MPPP ( 1-methyl-4-phenyl-4-propion-oxy-piperidine ) is an analgesic opioid , which is also known as synthetic heroin as a designer drug . Structurally it is the reverse ester of pethidine .
The improper manufacture of MPPP produces the nerve toxin MPTP , which causes irreversible Parkinson's- like damage. The correct synthesis of MPPP takes place slowly and with little heat. If a large amount of heat is applied, a large amount of MPTP is produced during the synthesis through the elimination reaction .
MPPP is listed as a non-marketable substance in the BtMG .
Individual evidence
- ↑ This substance has either not yet been classified with regard to its hazardousness or a reliable and citable source has not yet been found.
- ↑ Langston, JW et al. (1983): Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. In: Science. 219 (4587): 979-980, PMID 6823561 .